Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Free Cash Flow (2016 - 2025)

Iradimed (IRMD) has disclosed Free Cash Flow for 13 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 122.88% to -$1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.2 million through Dec 2025, down 30.75% year-over-year, with the annual reading at $17.2 million for FY2025, 30.75% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$1.3 million at Iradimed, down from $12.8 million in the prior quarter.
  • The five-year high for Free Cash Flow was $12.8 million in Q3 2025, with the low at -$5.2 million in Q3 2023.
  • Average Free Cash Flow over 5 years is $3.8 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Free Cash Flow soared 379.87% in 2021, then plummeted 238.33% in 2023.
  • Over 5 years, Free Cash Flow stood at $3.3 million in 2021, then decreased by 15.14% to $2.8 million in 2022, then soared by 268.77% to $10.3 million in 2023, then plummeted by 44.22% to $5.7 million in 2024, then tumbled by 122.88% to -$1.3 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$1.3 million, $12.8 million, and $5.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.